Novartis India Limited (NOVARTIND.BO)

INR 998.85

(-1.78%)

Total Debt Summary of Novartis India Limited

  • Novartis India Limited's latest annual total debt in 2023 was 69.7 Million INR , down -67.6% from previous year.
  • Novartis India Limited's latest quarterly total debt in 2024 Q2 was 19.5 Million INR , down 0.0% from previous quarter.
  • Novartis India Limited reported annual total debt of 215.1 Million INR in 2022, down -10.41% from previous year.
  • Novartis India Limited reported annual total debt of 240.1 Million INR in 2021, down -61.57% from previous year.
  • Novartis India Limited reported quarterly total debt of - INR for 2024 Q1, down -100.0% from previous quarter.
  • Novartis India Limited reported quarterly total debt of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Debt Chart of Novartis India Limited (2023 - 2007)

Historical Annual Total Debt of Novartis India Limited (2023 - 2007)

Year Total Debt Total Debt Growth
2023 69.7 Million INR -67.6%
2022 215.1 Million INR -10.41%
2021 240.1 Million INR -61.57%
2020 624.8 Million INR -8.51%
2019 682.9 Million INR 0.0%
2018 - INR 0.0%
2017 - INR 0.0%
2016 - INR -100.0%
2015 56.9 Million INR 0.0%
2014 - INR -100.0%
2013 1.2 Million INR -33.33%
2012 1.8 Million INR 28.57%
2011 1.4 Million INR 0.0%
2010 - INR -100.0%
2009 2.69 Million INR -9.73%
2008 2.98 Million INR -32.21%
2007 4.39 Million INR 0.0%

Peer Total Debt Comparison of Novartis India Limited

Name Total Debt Total Debt Difference
Ajanta Pharma Limited 352.8 Million INR 80.244%
Amrutanjan Health Care Limited 17.28 Million INR -303.286%
Sigachi Industries Limited 1.43 Billion INR 95.128%
Bal Pharma Limited 1.39 Billion INR 95.009%
Ind-Swift Laboratories Limited 166.21 Million INR 58.067%
Medico Remedies Limited 80.5 Million INR 13.42%
Lasa Supergenerics Limited 220.76 Million INR 68.428%
Venus Remedies Limited 413.3 Million INR 83.136%
Sun Pharma Advanced Research Company Limited 611.5 Million INR 88.602%
Alpa Laboratories Limited 52.46 Million INR -32.85%
Nectar Lifesciences Limited 6.35 Billion INR 98.903%
Shilpa Medicare Limited 9.37 Billion INR 99.256%
Aarti Drugs Limited 5.64 Billion INR 98.765%
Lupin Limited 29.21 Billion INR 99.761%
Aurobindo Pharma Limited 66.47 Billion INR 99.895%
Zydus Lifesciences Limited 8.04 Billion INR 99.133%
Windlas Biotech Limited 36.41 Million INR -91.431%
Suven Life Sciences Limited 7.09 Million INR -882.105%
Eris Lifesciences Limited 27.81 Billion INR 99.749%
Valiant Laboratories Limited 767.08 Million INR 90.914%
J. B. Chemicals & Pharmaceuticals Limited 3.77 Billion INR 98.154%
Solara Active Pharma Sciences Limited 10.11 Billion INR 99.311%
Ipca Laboratories Limited 14.38 Billion INR 99.515%
Bliss GVS Pharma Limited 998.4 Million INR 93.019%
Achyut Healthcare Limited - INR -Infinity%
Sun Pharmaceutical Industries Limited 32.73 Billion INR 99.787%
Bajaj HealthCare Limited 3.32 Billion INR 97.906%
RPG Life Sciences Limited - INR -Infinity%
Mankind Pharma Limited 2.07 Billion INR 96.636%
Laurus Labs Limited 25.77 Billion INR 99.73%
Piramal Pharma Limited 47.1 Billion INR 99.852%
Syncom Formulations (India) Limited 724.86 Million INR 90.384%
Torrent Pharmaceuticals Limited 40.22 Billion INR 99.827%
Alembic Pharmaceuticals Limited 5.13 Billion INR 98.642%
Glenmark Pharmaceuticals Limited 12.3 Billion INR 99.434%
Unichem Laboratories Limited 2.47 Billion INR 97.184%
Sequent Scientific Limited 4.87 Billion INR 98.571%
Wanbury Limited 1.16 Billion INR 94.016%
Suven Pharmaceuticals Limited 649.96 Million INR 89.276%
Wockhardt Limited 23.56 Billion INR 99.704%
Themis Medicare Limited 957.92 Million INR 92.724%
Jagsonpal Pharmaceuticals Limited 89.41 Million INR 22.045%
Jubilant Pharmova Limited 36.64 Billion INR 99.81%
Glenmark Life Sciences Limited 171.48 Million INR 59.354%
Dr. Reddy's Laboratories Limited 20.02 Billion INR 99.652%
Divi's Laboratories Limited 30 Million INR -132.333%
NATCO Pharma Limited 3.71 Billion INR 98.122%
Gufic Biosciences Limited 3.32 Billion INR 97.906%
IOL Chemicals and Pharmaceuticals Limited 327.6 Million INR 78.724%
Ind-Swift Limited 10.13 Billion INR 99.313%
Procter & Gamble Health Limited 95.6 Million INR 27.092%
FDC Limited 205.18 Million INR 66.031%
Krebs Biochemicals & Industries Limited 1.93 Billion INR 96.397%
Granules India Limited 13.15 Billion INR 99.47%
Medicamen Biotech Limited 308.17 Million INR 77.383%
Alkem Laboratories Limited 14.18 Billion INR 99.509%
AstraZeneca Pharma India Limited 45.98 Million INR -51.581%
Biofil Chemicals and Pharmaceuticals Limited 4.38 Million INR -1488.061%
Brooks Laboratories Limited 56.41 Million INR -23.54%
Megasoft Limited 1.47 Billion INR 95.26%
ZIM Laboratories Limited 1.08 Billion INR 93.595%
Strides Pharma Science Limited 25.16 Billion INR 99.723%
Neuland Laboratories Limited 953.89 Million INR 92.693%
Morepen Laboratories Limited 289.99 Million INR 75.965%
Hikal Limited 8.17 Billion INR 99.147%
Indoco Remedies Limited 6.71 Billion INR 98.963%
Aarti Pharmalabs Limited 2.85 Billion INR 97.557%
Kilitch Drugs (India) Limited 316.46 Million INR 77.975%
Mangalam Drugs & Organics Limited 984.92 Million INR 92.923%
Hester Biosciences Limited 2.44 Billion INR 97.148%